SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001185185-24-000490
Filing Date
2024-05-13
Accepted
2024-05-13 21:53:35
Documents
1
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2467
  Complete submission text file 0001185185-24-000490.txt   4218
Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-983-0998
IGC Pharma, Inc. (Issuer) CIK: 0001326205 (see all company filings)

IRS No.: 202760393 | State of Incorp.: MD | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address UNIT 5106-7, 51ST FLOOR THE CENTER 99 QUEENS ROAD CENTRAL CENTRAL K3 999077
Business Address UNIT 5106-7, 51ST FLOOR THE CENTER 99 QUEENS ROAD CENTRAL CENTRAL K3 999077 85239083300
Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857) (Reporting) CIK: 0002022777 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32830 | Film No.: 24941225